Interferon-γ Therapy in Patients With Refractory Disseminated Coccidioidomycosis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 40440413.
- Also identified by DOI 10.1093/cid/ciaf286.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Refractory disseminated coccidioidomycosis (DCM) is a severe disease with limited treatment options. This report reviews our own and prior published experiences using adjunctive interferon-γ therapy in refractory DCM, showing overall favorable responses in patients without signal transducer and activator of transcription 1 gain-of-function mutations.
Medical subject headings
- Coccidioidomycosis
- Interferon-gamma
- Antifungal Agents